Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury

Background: Allograft lung ischemia-reperfusion injury (ALIRI) is a major cause of early primary graft dysfunction and poor long-term survival after lung transplantation (LTx); however, its pathogenesis has not been fully elucidated. Cell death is a mechanism underlying ALIRI. Cuproptosis is a recen...

Full description

Bibliographic Details
Main Authors: Jianying Qin, Xiaoyue Xiao, Silin Li, Ning Wen, Ke Qin, Haibin Li, Jihua Wu, Bing Lu, Minghu Li, Xuyong Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1269478/full
_version_ 1797488653031702528
author Jianying Qin
Jianying Qin
Jianying Qin
Xiaoyue Xiao
Silin Li
Silin Li
Silin Li
Ning Wen
Ning Wen
Ning Wen
Ke Qin
Ke Qin
Ke Qin
Haibin Li
Haibin Li
Haibin Li
Jihua Wu
Jihua Wu
Jihua Wu
Bing Lu
Bing Lu
Bing Lu
Minghu Li
Minghu Li
Minghu Li
Xuyong Sun
Xuyong Sun
Xuyong Sun
author_facet Jianying Qin
Jianying Qin
Jianying Qin
Xiaoyue Xiao
Silin Li
Silin Li
Silin Li
Ning Wen
Ning Wen
Ning Wen
Ke Qin
Ke Qin
Ke Qin
Haibin Li
Haibin Li
Haibin Li
Jihua Wu
Jihua Wu
Jihua Wu
Bing Lu
Bing Lu
Bing Lu
Minghu Li
Minghu Li
Minghu Li
Xuyong Sun
Xuyong Sun
Xuyong Sun
author_sort Jianying Qin
collection DOAJ
description Background: Allograft lung ischemia-reperfusion injury (ALIRI) is a major cause of early primary graft dysfunction and poor long-term survival after lung transplantation (LTx); however, its pathogenesis has not been fully elucidated. Cell death is a mechanism underlying ALIRI. Cuproptosis is a recently discovered form of programmed cell death. To date, no studies have been conducted on the mechanisms by which cuproptosis-related genes (CRGs) regulate ALIRI. Therefore, we explored the potential biomarkers related to cuproptosis to provide new insights into the treatment of ALIRI.Materials and methods: Datasets containing pre- and post-LTx lung biopsy samples and CRGs were obtained from the GEO database and previous studies. We identified differentially expressed CRGs (DE-CRGs) and performed functional analyses. Biomarker genes were selected using three machine learning algorithms. The ROC curve and logistic regression model (LRM) of these biomarkers were constructed. CIBERSORT was used to calculate the number of infiltrating immune cells pre- and post-LTx, and the correlation between these biomarkers and immune cells was analyzed. A competing endogenous RNA network was constructed using these biomarkers. Finally, the biomarkers were verified in a validation set and a rat LTx model using qRT-PCR and Western blotting.Results: Fifteen DE-CRGs were identified. GO analysis revealed that DE-CRGs were significantly enriched in the mitochondrial acetyl-CoA biosynthetic process from pyruvate, protein lipoylation, the tricarboxylic acid (TCA) cycle, and copper-transporting ATPase activity. KEGG enrichment analysis showed that the DE-CRGs were mainly enriched in metabolic pathways, carbon metabolism, and the TCA cycle. NFE2L2, NLRP3, LIPT1, and MTF1 were identified as potential biomarker genes. The AUC of the ROC curve for each biomarker was greater than 0.8, and the LRM provided an excellent classifier with an AUC of 0.96. These biomarkers were validated in another dataset and a rat LTx model, which exhibited good performance. In the CIBERSORT analysis, differentially expressed immune cells were identified, and the biomarkers were associated with the immune cells.Conclusion:NFE2L2, NLRP3, LIPT1, and MTF1 may serve as predictors of cuproptosis and play an important role in the pathogenesis of cuproptosis in ALIRI.
first_indexed 2024-03-10T00:05:22Z
format Article
id doaj.art-8225ed140ca447e7b36548221a0f868b
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-03-10T00:05:22Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-8225ed140ca447e7b36548221a0f868b2023-11-23T16:08:40ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-11-011010.3389/fmolb.2023.12694781269478Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injuryJianying Qin0Jianying Qin1Jianying Qin2Xiaoyue Xiao3Silin Li4Silin Li5Silin Li6Ning Wen7Ning Wen8Ning Wen9Ke Qin10Ke Qin11Ke Qin12Haibin Li13Haibin Li14Haibin Li15Jihua Wu16Jihua Wu17Jihua Wu18Bing Lu19Bing Lu20Bing Lu21Minghu Li22Minghu Li23Minghu Li24Xuyong Sun25Xuyong Sun26Xuyong Sun27Transplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaDepartment of Pathology, The Fifth Affiliated Hospital of Guangxi Medical University, The First People’s Hospital of Nanning, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaTransplant Medical Center, The Second Affiliated Hospital of Guangxi Medical University, Nanning, ChinaGuangxi Clinical Research Center for Organ Transplantation, Nanning, ChinaGuangxi Key Laboratory of Organ Donation and Transplantation, Nanning, ChinaBackground: Allograft lung ischemia-reperfusion injury (ALIRI) is a major cause of early primary graft dysfunction and poor long-term survival after lung transplantation (LTx); however, its pathogenesis has not been fully elucidated. Cell death is a mechanism underlying ALIRI. Cuproptosis is a recently discovered form of programmed cell death. To date, no studies have been conducted on the mechanisms by which cuproptosis-related genes (CRGs) regulate ALIRI. Therefore, we explored the potential biomarkers related to cuproptosis to provide new insights into the treatment of ALIRI.Materials and methods: Datasets containing pre- and post-LTx lung biopsy samples and CRGs were obtained from the GEO database and previous studies. We identified differentially expressed CRGs (DE-CRGs) and performed functional analyses. Biomarker genes were selected using three machine learning algorithms. The ROC curve and logistic regression model (LRM) of these biomarkers were constructed. CIBERSORT was used to calculate the number of infiltrating immune cells pre- and post-LTx, and the correlation between these biomarkers and immune cells was analyzed. A competing endogenous RNA network was constructed using these biomarkers. Finally, the biomarkers were verified in a validation set and a rat LTx model using qRT-PCR and Western blotting.Results: Fifteen DE-CRGs were identified. GO analysis revealed that DE-CRGs were significantly enriched in the mitochondrial acetyl-CoA biosynthetic process from pyruvate, protein lipoylation, the tricarboxylic acid (TCA) cycle, and copper-transporting ATPase activity. KEGG enrichment analysis showed that the DE-CRGs were mainly enriched in metabolic pathways, carbon metabolism, and the TCA cycle. NFE2L2, NLRP3, LIPT1, and MTF1 were identified as potential biomarker genes. The AUC of the ROC curve for each biomarker was greater than 0.8, and the LRM provided an excellent classifier with an AUC of 0.96. These biomarkers were validated in another dataset and a rat LTx model, which exhibited good performance. In the CIBERSORT analysis, differentially expressed immune cells were identified, and the biomarkers were associated with the immune cells.Conclusion:NFE2L2, NLRP3, LIPT1, and MTF1 may serve as predictors of cuproptosis and play an important role in the pathogenesis of cuproptosis in ALIRI.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1269478/fullcuproptosisischemia-reperfusion injuryallograft lungbiomarkersimmune infiltration
spellingShingle Jianying Qin
Jianying Qin
Jianying Qin
Xiaoyue Xiao
Silin Li
Silin Li
Silin Li
Ning Wen
Ning Wen
Ning Wen
Ke Qin
Ke Qin
Ke Qin
Haibin Li
Haibin Li
Haibin Li
Jihua Wu
Jihua Wu
Jihua Wu
Bing Lu
Bing Lu
Bing Lu
Minghu Li
Minghu Li
Minghu Li
Xuyong Sun
Xuyong Sun
Xuyong Sun
Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury
Frontiers in Molecular Biosciences
cuproptosis
ischemia-reperfusion injury
allograft lung
biomarkers
immune infiltration
title Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury
title_full Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury
title_fullStr Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury
title_full_unstemmed Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury
title_short Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury
title_sort identification of cuproptosis related biomarkers and analysis of immune infiltration in allograft lung ischemia reperfusion injury
topic cuproptosis
ischemia-reperfusion injury
allograft lung
biomarkers
immune infiltration
url https://www.frontiersin.org/articles/10.3389/fmolb.2023.1269478/full
work_keys_str_mv AT jianyingqin identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT jianyingqin identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT jianyingqin identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT xiaoyuexiao identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT silinli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT silinli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT silinli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT ningwen identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT ningwen identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT ningwen identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT keqin identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT keqin identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT keqin identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT haibinli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT haibinli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT haibinli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT jihuawu identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT jihuawu identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT jihuawu identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT binglu identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT binglu identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT binglu identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT minghuli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT minghuli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT minghuli identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT xuyongsun identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT xuyongsun identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury
AT xuyongsun identificationofcuproptosisrelatedbiomarkersandanalysisofimmuneinfiltrationinallograftlungischemiareperfusioninjury